Janus Henderson Group’s Pacira BioSciences PCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $601K | Hold |
|
|||||
|
2025
Q2 | $557K | Hold |
|
|||||
|
2025
Q1 | $581K | Hold |
|
|||||
|
2024
Q4 | $439K | Hold |
|
|||||
|
2024
Q3 | $351K | Sell |
|
|||||
|
2024
Q2 | $20M | Buy |
|
|||||
|
2024
Q1 | $17.6M | Sell |
|
|||||
|
2023
Q4 | $20.4M | Buy |
|
|||||
|
2023
Q3 | $16.5M | Buy |
|
|||||
|
2023
Q2 | $14.2M | Buy |
|
|||||
|
2023
Q1 | $808K | Buy |
|
|||||
|
2022
Q4 | $341K | Buy |
|
|||||
|
2022
Q3 | $470K | Buy |
|
|||||
|
2022
Q2 | $514K | Sell |
|
|||||
|
2022
Q1 | $674K | Sell |
|
|||||
|
2021
Q4 | $2.39M | Sell |
|
|||||
|
2021
Q3 | $3.47M | Sell |
|
|||||
|
2021
Q2 | $4.39M | Sell |
|
|||||
|
2021
Q1 | $5.42M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $12.2M | Buy |
|
|||||
|
2015
Q3 | $5.49M | Buy |
|
|||||
|
2015
Q2 | $7.6M | Buy |
|
|||||
|
2015
Q1 | $8.7M | Buy |
|
|||||
|
2014
Q4 | $5.8M | Buy |
|
|||||
|
2014
Q3 | $5.22M | Buy |
|